Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for TGF-BETA- UND ACTRII-ANTAGONISTEN ZUR BEHANDLUNG VON LEUKÄMIE
Details for 2018747362
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2018747362
Title / Product Name
TGF-BETA- UND ACTRII-ANTAGONISTEN ZUR BEHANDLUNG VON LEUKÄMIE
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2018747362
EP Publication Number
3576773
E-Number
1621842
Language
EN
PCT Number
US18016148
Publication Date
11.12.2019 A
18.10.2023 B1
Registration Date
18.10.2023
AT Publication Date
15.11.2023
Application Date
31.01.2018
Registration Number
-
Priorities
01.02.2017
US
201762453413 P
IPC
A61K 38/17 20060101AFI20200706BHEP
Maximum Duration of Protection
31.01.2038
Owner
Acceleron Pharma Inc.
128 Sidney Street
Cambridge, MA 02139
US
Representative
No representatives present
Inventor
PEARSALL, Robert Scott
8 Winterberry Lane
North Reading, MA 01864
US
KUMAR, Ravindra
421 Arlington Street
Acton, MA 01720
US